Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Mo

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Acta Haematologica|March 13, 2026
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Pregnancy-Associated Aplastic AnemiaXinxin Li, Liangliang Wu, Yumiao Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2019
Comparable Outcomes of First-Line Hematopoietic Stem Cell Transplantation from Unrelated and Matched Sibling Donors in Adult Patients with Aplastic Anemia: A Retrospective Single-Center StudyYuping Zhang, Liangliang Wu, Wenjian Mo, et al.
Transplantation and Cellular Therapy|April 25, 2023
Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical TransplantationLiangliang Wu, Ming Zhou, Yumiao Li, et al.
Iscience|November 3, 2022
The establishment of a cytomegalovirus -specific CD8<sup>+</sup> T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivationJing Zhang, Jinpeng Cao, Runhui Zheng, et al.
Transplantation and Cellular Therapy|June 14, 2025
Comparative study of Bu/Cy/ATG and Flu/Cy/ATG conditioning regimens for unrelated donor hematopoietic stem cell transplantation in severe aplastic anemiaLiangliang Wu, Xiaowei Chen, Ming Zhou, et al.
British Journal of Haematology|September 15, 2025
Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemiaLiangliang Wu, Ming Zhou, Xiaowei Chen, et al.
Infectious Diseases and Therapy|January 24, 2024
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort StudyYuling Zhang, Xiaowei Chen, Ming Zhou, et al.
Cellular Signalling|February 15, 2025
STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenanceXue Han, Kexin Wang, Songqi Zhu, et al.
Transplantation and Cellular Therapy|August 26, 2024
Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective StudyXiaowei Chen, Cunte Chen, Ming Zhou, et al.
Blood Cells, Molecules & Diseases|May 1, 2026
Delay in cell infusion improves GVHD and clinical outcomes in severe aplastic anemia patients >30 years receiving unrelated donor hematopoietic stem cell transplantationJinrong Zhao, Xiaowei Chen, Liangliang Wu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Acta Haematologica|March 13, 2026
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Pregnancy-Associated Aplastic AnemiaXinxin Li, Liangliang Wu, Yumiao Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2019
Comparable Outcomes of First-Line Hematopoietic Stem Cell Transplantation from Unrelated and Matched Sibling Donors in Adult Patients with Aplastic Anemia: A Retrospective Single-Center StudyYuping Zhang, Liangliang Wu, Wenjian Mo, et al.
Transplantation and Cellular Therapy|April 25, 2023
Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical TransplantationLiangliang Wu, Ming Zhou, Yumiao Li, et al.
Iscience|November 3, 2022
The establishment of a cytomegalovirus -specific CD8<sup>+</sup> T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivationJing Zhang, Jinpeng Cao, Runhui Zheng, et al.
Transplantation and Cellular Therapy|June 14, 2025
Comparative study of Bu/Cy/ATG and Flu/Cy/ATG conditioning regimens for unrelated donor hematopoietic stem cell transplantation in severe aplastic anemiaLiangliang Wu, Xiaowei Chen, Ming Zhou, et al.
British Journal of Haematology|September 15, 2025
Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemiaLiangliang Wu, Ming Zhou, Xiaowei Chen, et al.
Infectious Diseases and Therapy|January 24, 2024
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort StudyYuling Zhang, Xiaowei Chen, Ming Zhou, et al.
Cellular Signalling|February 15, 2025
STAT1 inhibition promotes oxidative stress to sustain leukemia stem cell maintenanceXue Han, Kexin Wang, Songqi Zhu, et al.
Transplantation and Cellular Therapy|August 26, 2024
Efficacy of a Modified Post-Transplant Cyclophosphamide Regimen for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Prospective StudyXiaowei Chen, Cunte Chen, Ming Zhou, et al.
Blood Cells, Molecules & Diseases|May 1, 2026
Delay in cell infusion improves GVHD and clinical outcomes in severe aplastic anemia patients >30 years receiving unrelated donor hematopoietic stem cell transplantationJinrong Zhao, Xiaowei Chen, Liangliang Wu, et al.
Pageof 5